-
TianShiWei Raises Tens of Millions in Series A for Medical Aesthetics Expansion
•
hina-based Wuhan TianShiWei Biotechnology Co., Ltd has reportedly raised tens of millions of renminbi in a Series A financing round, solely funded by Co-win Ventures. The proceeds will be used for talent recruitment, business expansion in the medical aesthetics and personal care field, and research and development of medical devices.…
-
BeiGene Partners with Jilin Cancer Hospital for Cancer Drug Development
•
China-based BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) has entered into a clinical study partnership with Jilin Cancer Hospital. The collaboration is based on the hospital’s “Malignancy New Drug Creation Platform” and aims to bolster cancer drug development and accelerate BeiGene’s drug development activities. Financial details of the partnership were…
-
China Ramps Up Monitoring of Clinically Shortage Drugs Involving 109 Varieties
•
The Ministry of Industry and Information Technology (MIIT), National Health Commission (NHC), National Healthcare Security Administration (NHSA), and National Medical Products Administration (NMPA) have jointly released a notification to enhance the monitoring of drugs in clinical shortage. The notice includes a list of 109 drug varieties, with volume – based…
-
Arbele’s ARB202 Enters Phase I Trial for Advanced Gastrointestinal Cancer
•
Hong Kong-based biopharma Arbele announced that its CDH17 × CD3 bispecific T-Cell engager antibody, ARB202, has entered a Phase I clinical trial in the United States for advanced gastrointestinal cancer patients. The potential first-in-class drug has been dosed in the first patient, with the Phase I multi-center, open-label dose-escalation study…
-
ByteDance Acquires Amcare Healthcare for USD1.5b via Xiaohe Health Unit
•
ByteDance Ltd, the parent company of social media platforms TikTok and Douyin, has acquired Amcare Healthcare, a chain of high-end private hospitals in China. The deal, valued at USD1.5 billion according to Bloomberg, was executed by ByteDance’s healthcare unit Xiaohe Health. About Amcare HealthcareAmcare Healthcare was established in Beijing in…
-
Taihu Bay Healthcare Conference Launches Wuxi IP Protection Center
•
The 2022 Taihu Bay Future Healthcare Conference was held in Wuxi City, Jiangsu province, China, last week. The event marked the launch of the Wuxi Intellectual Property (IP) Protection Center. The center already has 52 contracted biomedical projects with a cumulative investment of over RMB30 billion. Biomedical Parks and PlatformsIn…
-
United Imaging Healthcare’s STAR Listing Raises USD1.85 Billion
•
Shanghai-based United Imaging Healthcare (UIH) has completed an initial public offering (IPO) of 100 million shares on the Shanghai Stock Exchange’s Sci-Tech Innovation Board (STAR). The listing raised RMB12.48 billion (USD1.85 billion) for the firm, bringing its post-listing market capitalization to around RMB100 billion. Company BackgroundFounded in 2011, UIH focuses…
-
Boston Scientific’s Rezūm System Installed in China’s Urinary Innovation Center
•
US major Boston Scientific Corporation (NYSE: BSX) has jointly established the “Urinary Joint Innovation Center” and “Rezūm Academic Exchange Training Center” in China with ParkwayHealth and YiRan Urology. Boston Scientific’s Rezūm hot steam treatment equipment and disposable prostate hot steam treatment equipment was installed in the center for the first…
